Why Glucagon Matters for Hypoglycemia and Physical Activity in Individuals With Type 1 Diabetes

Why Glucagon Matters for Hypoglycemia and Physical Activity in Individuals With Type 1 Diabetes

Bibliographic Details
Main Author:	Sheri R. Colberg
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-07-01
Series:	Frontiers in Clinical Diabetes and Healthcare
Subjects:	glucagon insulin physical activity type 1 diabetes blood glucose counterregulatory hormones
Online Access:	https://www.frontiersin.org/articles/10.3389/fcdhc.2022.889248/full

Similar Items

Managing Severe Hypoglycaemia in Patients with Diabetes: Current Challenges and Emerging Therapies
by: Demirbilek H, et al.
Published: (2023-01-01)

Current perspective on the role of insulin and glucagon in the pathogenesis and treatment of type 2 diabetes mellitus
by: Ojha A, et al.
Published: (2019-05-01)

Blockade of glucagon signaling prevents or reverses diabetes onset only if residual β-cells persist
by: Nicolas Damond, et al.
Published: (2016-04-01)

Experimental pharmacological approaches to reverse impaired awareness of hypoglycemia—a review
by: Hiba Z. Hashmi, et al.
Published: (2024-01-01)

Still Excited, but Less Aroused—The Effects of Nutritional Ketosis on Epinephrine Response and Hypothalamic Orexin Neuron Activation Following Recurrent Hypoglycemia in Diabetic Rats
by: Polina E. Nedoboy, et al.
Published: (2022-12-01)

Insulin and glucagon levels of umbilical cord blood in appropriate for gestational age - preterm infants with or without postnatal hypoglycemia
by: Jae Hyun Park, et al.
Published: (2016-06-01)

An Evaluation of Glucagon Injection Anxiety and Its Association with the Fear of Hypoglycemia among the Parents of Children with Type 1 Diabetes
by: Serra Muradoğlu, et al.
Published: (2021-09-01)

Comparative Effects of Co-Ingesting Whey Protein and Glucose Alone and Combined on Blood Glucose, Plasma Insulin and Glucagon Concentrations in Younger and Older Men
by: Avneet Oberoi, et al.
Published: (2022-07-01)

Pharmacologic inhibition of somatostatin receptor 2 to restore glucagon counterregulation in diabetes
by: Emily G. Hoffman, et al.
Published: (2024-01-01)

New uses and formulations of glucagon for hypoglycaemia
by: Pilar I Beato-Víbora, et al.
Published: (2019-07-01)

Practical therapeutic approach in the management of diabetes mellitus secondary to Cushing’s syndrome, acromegaly and neuroendocrine tumours
by: Valentina Guarnotta, et al.
Published: (2023-09-01)

Glucagon kinetics assessed by mathematical modelling during oral glucose administration in people spanning from normal glucose tolerance to type 2 diabetes
by: Francesco Andreozzi, et al.
Published: (2024-04-01)

The ventromedial hypothalamic nucleus: watchdog of whole-body glucose homeostasis
by: Longlong Tu, et al.
Published: (2022-05-01)

“It’s embarrassing. I get angry. I get frustrated.”: Understanding severe hypoglycemia and glucagon usage from the perspectives of people with type 1 diabetes
by: Allyson S. Hughes, et al.
Published: (2022-12-01)

Hypoglycemia after Mitral Valve Repair in Dogs
by: Yasuyuki Nii, et al.
Published: (2024-02-01)

Post Meal Exercise May Lead to Transient Hypoglycemia Irrespective of Glycemic Status in Humans
by: Jay W. Porter, et al.
Published: (2020-09-01)

Assessment of Two Different Glucagon Assays in Healthy Individuals and Type 1 and Type 2 Diabetes Patients
by: Martina Brunner, et al.
Published: (2022-03-01)

Inhaled glucagon: A new hope for severe hypoglycemia in type 1 diabetes
by: Salva Fatima Heba, et al.
Published: (2021-01-01)

Mini‐review: Glucagon responses in type 1 diabetes – a matter of complexity
by: Mads Bisgaard Bengtsen, et al.
Published: (2021-08-01)

Partners for life
by: Lena Eliasson, et al.
Published: (2016-05-01)

Subcutaneous glucagon infusion and continuous glucose monitoring enable effective management of hypoglycemia in a patient with IGF-2-producing hemangiopericytoma
by: Eric D. Buras, et al.
Published: (2018-01-01)

Association of Glucagon to Insulin Ratio and Metabolic Syndrome in Patients with Type 2 Diabetes
by: Jisun Bang, et al.
Published: (2023-09-01)

An Animation-Enhanced Presentation for Illustrating Hormonal and Metabolite Regulation of Metabolic Pathways in the Context of Diabetes
by: Eric Niederhoffer
Published: (2014-01-01)

Near-miss hypoglycemia—reflections on perioperative glucose management guidelines in diabetics
by: Rabeel Ahmad, et al.
Published: (2023-06-01)

Glucagon as a Therapeutic Approach to Severe Hypoglycemia: After 100 Years, Is It Still the Antidote of Insulin?
by: Francesca Porcellati, et al.
Published: (2021-08-01)

The Change in Glucagon Following Meal Ingestion Is Associated with Glycemic Control, but Not with Incretin, in People with Diabetes
by: Soyeon Yoo, et al.
Published: (2021-06-01)

Effects of Low-Dose Glucagon on Subcutaneous Insulin Absorption in Pigs
by: Ingrid Anna Teigen, M.D., Ph.D., et al.
Published: (2024-01-01)

The effect of exogenous glucagon on circulating amino acids in individuals with and without type 2 diabetes and obesity
by: Magnus F G Grøndahl, et al.
Published: (2024-02-01)

Higher glucagon-to-insulin ratio is associated with elevated glycated hemoglobin levels in type 2 diabetes patients
by: Minyoung Lee, et al.
Published: (2019-09-01)

Gender effect of glucose, insulin/glucagon ratio, lipids, and nitrogen-metabolites on serum HGF and EGF levels in patients with diabetes type 2
by: Martha Lucinda Contreras-Zentella, et al.
Published: (2024-04-01)

Lowest Glucagon/Highest C-Peptide in Oral Glucose Tolerance Test: Clinical Utility in Monitoring Glucose Control in Type 2 Diabetes Mellitus
by: Chang L, et al.
Published: (2024-04-01)

A glucose-insulin-glucagon coupled model of the isoglycemic intravenous glucose infusion experiment
by: Vijaya Subramanian, et al.
Published: (2022-09-01)

New Potential Targets of Glucagon-Like Peptide 1 Receptor Agonists in Pancreatic β-Cells and Hepatocytes
by: Won-Young Lee
Published: (2017-02-01)

Study of the serum level of fasting glucagon-like peptide-1 in type 2 diabetics and its relation to the glycemic profile
by: Mohamed A Korani, et al.
Published: (2018-01-01)

Role of Glucagon and Its Receptor in the Pathogenesis of Diabetes
by: Yunbo Jia, et al.
Published: (2022-06-01)

Insulin–glucagon‐like peptide‐1 receptor agonist relay and glucagon‐like peptide‐1 receptor agonist first regimens in individuals with type 2 diabetes: A randomized, open‐label trial study
by: Yumie Takeshita, et al.
Published: (2022-06-01)

The Role of Glucagon in Glycemic Variability in Type 1 Diabetes: A Narrative Review
by: Guo K, et al.
Published: (2021-12-01)

Hepatic glucagon receptors expression in response to glucose, insulin, glucagon and immune challenge in grass carp (Ctenophcuyngodon idellus)
by: Chaobin Qin, et al.
Published: (2020-11-01)

Possible mechanisms of the hypoglycaemic effect of artesunate: Gender implication
by: Abdullateef Isiaka Alagbonsi, et al.
Published: (2021-06-01)

New Fast Acting Glucagon for Recovery from Hypoglycemia, a Life-Threatening Situation: Nasal Powder and Injected Stable Solutions
by: Lucia La Sala, et al.
Published: (2021-09-01)